Please login to the form below

Not currently logged in
Email:
Password:

QuintilesIMS changes its name to IQVIA

Firm will focus on human data science solutions

IQVIAA year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA.

Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ taken from Quintiles.

However, the latter and newest part of the name - ‘via’  - is representative of “seeking to inspire and ignite real change via a new path forward”, explains Ari Bousbib, chief executive officer of IQVIA.

Bousbib added: “We launched as QuintilesIMS, then we built something transformational and that is how we became IQVIA.

“We aim to bring the potential of human data science to life to find better solutions for patients.”

The group has a slightly different offering from when it first became QuintilesIMS, which was due to a mega-merger of healthcare services provider Quintiles and information and technology group IMS, offering pharma clients an end-to-end clinical and commercial package.

Now, the newly-named group will provide solutions to healthcare companies through analytics, data science and human science, claiming expertise in research and development, real-world value and outcomes, commercialisation and technologies.

Article by
Gemma Jones

10th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics